Bronchoconstriction and pulmonary hypertension during abortion induced by 15-methyl-prostaglandin F2alpha

Patients have experienced severe breathlessness during second trimester abortion initiated by the intramuscular injection of 15-methyl-prostaglandin F2alpha (15-me-PGF2alpha). In four healthy women given 400 mug of 15-me-PGF2alpha to induce abortion, pulmonary function tests showed reductions in art...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of medicine 1976-04, Vol.60 (4), p.556
Hauptverfasser: Weir, E K, Greer, B E, Smith, S C, Silvers, G W, Droegemueller, W, Reeves, J T, Grover, R F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 4
container_start_page 556
container_title The American journal of medicine
container_volume 60
creator Weir, E K
Greer, B E
Smith, S C
Silvers, G W
Droegemueller, W
Reeves, J T
Grover, R F
description Patients have experienced severe breathlessness during second trimester abortion initiated by the intramuscular injection of 15-methyl-prostaglandin F2alpha (15-me-PGF2alpha). In four healthy women given 400 mug of 15-me-PGF2alpha to induce abortion, pulmonary function tests showed reductions in arterial oxygen tension, maximum expired air flow and vital capacity. Residual lung volume and the slope of phase III of the closing volume curves increased.
doi_str_mv 10.1016/0002-9343(76)90723-3
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_1274990</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1274990</sourcerecordid><originalsourceid>FETCH-LOGICAL-p138t-918ba0f8d2187e28a1670d1c58aa87c6cb0c2eda6668bd695449dc3a8887e4493</originalsourceid><addsrcrecordid>eNo9T7tOwzAU9QAqpfAHIHmEweBH4tgjVC0gVWKBubqx3cYosS0nGfL3BKiYzlNHOgjdMPrAKJOPlFJOtCjEXSXvNa24IOIMLf_tC3TZ91-zpLqUC7RgvCq0pkvkn3MMpokmhn7I3gw-BgzB4jS2XQyQJ9xMyeXBhf4nsmP24Yihjvm36oMdjbO4njArSeeGZmpJyrEf4NjOOz7gLYc2NXCFzg_Q9u76hCv0ud18rF_J7v3lbf20I4kJNRDNVA30oCxnqnJcAZMVtcyUCkBVRpqaGu4sSClVbaUui0JbI0CpuT5zsUK3f7tprDtn9yn7br6xP10W33ZyWYY</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Bronchoconstriction and pulmonary hypertension during abortion induced by 15-methyl-prostaglandin F2alpha</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Weir, E K ; Greer, B E ; Smith, S C ; Silvers, G W ; Droegemueller, W ; Reeves, J T ; Grover, R F</creator><creatorcontrib>Weir, E K ; Greer, B E ; Smith, S C ; Silvers, G W ; Droegemueller, W ; Reeves, J T ; Grover, R F</creatorcontrib><description>Patients have experienced severe breathlessness during second trimester abortion initiated by the intramuscular injection of 15-methyl-prostaglandin F2alpha (15-me-PGF2alpha). In four healthy women given 400 mug of 15-me-PGF2alpha to induce abortion, pulmonary function tests showed reductions in arterial oxygen tension, maximum expired air flow and vital capacity. Residual lung volume and the slope of phase III of the closing volume curves increased.</description><identifier>ISSN: 0002-9343</identifier><identifier>DOI: 10.1016/0002-9343(76)90723-3</identifier><identifier>PMID: 1274990</identifier><language>eng</language><publisher>United States</publisher><subject>Abortion, Induced - adverse effects ; Adolescent ; Adult ; Blood Cell Count ; Blood Pressure - drug effects ; Bronchial Diseases - blood ; Bronchial Diseases - chemically induced ; Bronchial Diseases - physiopathology ; Carbon Dioxide - blood ; Female ; Forced Expiratory Flow Rates ; Functional Residual Capacity ; Humans ; Hypertension, Pulmonary - blood ; Hypertension, Pulmonary - chemically induced ; Hypertension, Pulmonary - physiopathology ; Maximal Midexpiratory Flow Rate ; Oxygen - blood ; Pregnancy ; Pregnancy Trimester, Second ; Prostaglandins F - adverse effects ; Prostaglandins F - pharmacology ; Prostaglandins F - therapeutic use ; Pulmonary Diffusing Capacity ; Vital Capacity - drug effects</subject><ispartof>The American journal of medicine, 1976-04, Vol.60 (4), p.556</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1274990$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Weir, E K</creatorcontrib><creatorcontrib>Greer, B E</creatorcontrib><creatorcontrib>Smith, S C</creatorcontrib><creatorcontrib>Silvers, G W</creatorcontrib><creatorcontrib>Droegemueller, W</creatorcontrib><creatorcontrib>Reeves, J T</creatorcontrib><creatorcontrib>Grover, R F</creatorcontrib><title>Bronchoconstriction and pulmonary hypertension during abortion induced by 15-methyl-prostaglandin F2alpha</title><title>The American journal of medicine</title><addtitle>Am J Med</addtitle><description>Patients have experienced severe breathlessness during second trimester abortion initiated by the intramuscular injection of 15-methyl-prostaglandin F2alpha (15-me-PGF2alpha). In four healthy women given 400 mug of 15-me-PGF2alpha to induce abortion, pulmonary function tests showed reductions in arterial oxygen tension, maximum expired air flow and vital capacity. Residual lung volume and the slope of phase III of the closing volume curves increased.</description><subject>Abortion, Induced - adverse effects</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Blood Cell Count</subject><subject>Blood Pressure - drug effects</subject><subject>Bronchial Diseases - blood</subject><subject>Bronchial Diseases - chemically induced</subject><subject>Bronchial Diseases - physiopathology</subject><subject>Carbon Dioxide - blood</subject><subject>Female</subject><subject>Forced Expiratory Flow Rates</subject><subject>Functional Residual Capacity</subject><subject>Humans</subject><subject>Hypertension, Pulmonary - blood</subject><subject>Hypertension, Pulmonary - chemically induced</subject><subject>Hypertension, Pulmonary - physiopathology</subject><subject>Maximal Midexpiratory Flow Rate</subject><subject>Oxygen - blood</subject><subject>Pregnancy</subject><subject>Pregnancy Trimester, Second</subject><subject>Prostaglandins F - adverse effects</subject><subject>Prostaglandins F - pharmacology</subject><subject>Prostaglandins F - therapeutic use</subject><subject>Pulmonary Diffusing Capacity</subject><subject>Vital Capacity - drug effects</subject><issn>0002-9343</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1976</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9T7tOwzAU9QAqpfAHIHmEweBH4tgjVC0gVWKBubqx3cYosS0nGfL3BKiYzlNHOgjdMPrAKJOPlFJOtCjEXSXvNa24IOIMLf_tC3TZ91-zpLqUC7RgvCq0pkvkn3MMpokmhn7I3gw-BgzB4jS2XQyQJ9xMyeXBhf4nsmP24Yihjvm36oMdjbO4njArSeeGZmpJyrEf4NjOOz7gLYc2NXCFzg_Q9u76hCv0ud18rF_J7v3lbf20I4kJNRDNVA30oCxnqnJcAZMVtcyUCkBVRpqaGu4sSClVbaUui0JbI0CpuT5zsUK3f7tprDtn9yn7br6xP10W33ZyWYY</recordid><startdate>197604</startdate><enddate>197604</enddate><creator>Weir, E K</creator><creator>Greer, B E</creator><creator>Smith, S C</creator><creator>Silvers, G W</creator><creator>Droegemueller, W</creator><creator>Reeves, J T</creator><creator>Grover, R F</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>197604</creationdate><title>Bronchoconstriction and pulmonary hypertension during abortion induced by 15-methyl-prostaglandin F2alpha</title><author>Weir, E K ; Greer, B E ; Smith, S C ; Silvers, G W ; Droegemueller, W ; Reeves, J T ; Grover, R F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p138t-918ba0f8d2187e28a1670d1c58aa87c6cb0c2eda6668bd695449dc3a8887e4493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1976</creationdate><topic>Abortion, Induced - adverse effects</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Blood Cell Count</topic><topic>Blood Pressure - drug effects</topic><topic>Bronchial Diseases - blood</topic><topic>Bronchial Diseases - chemically induced</topic><topic>Bronchial Diseases - physiopathology</topic><topic>Carbon Dioxide - blood</topic><topic>Female</topic><topic>Forced Expiratory Flow Rates</topic><topic>Functional Residual Capacity</topic><topic>Humans</topic><topic>Hypertension, Pulmonary - blood</topic><topic>Hypertension, Pulmonary - chemically induced</topic><topic>Hypertension, Pulmonary - physiopathology</topic><topic>Maximal Midexpiratory Flow Rate</topic><topic>Oxygen - blood</topic><topic>Pregnancy</topic><topic>Pregnancy Trimester, Second</topic><topic>Prostaglandins F - adverse effects</topic><topic>Prostaglandins F - pharmacology</topic><topic>Prostaglandins F - therapeutic use</topic><topic>Pulmonary Diffusing Capacity</topic><topic>Vital Capacity - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Weir, E K</creatorcontrib><creatorcontrib>Greer, B E</creatorcontrib><creatorcontrib>Smith, S C</creatorcontrib><creatorcontrib>Silvers, G W</creatorcontrib><creatorcontrib>Droegemueller, W</creatorcontrib><creatorcontrib>Reeves, J T</creatorcontrib><creatorcontrib>Grover, R F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>The American journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Weir, E K</au><au>Greer, B E</au><au>Smith, S C</au><au>Silvers, G W</au><au>Droegemueller, W</au><au>Reeves, J T</au><au>Grover, R F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bronchoconstriction and pulmonary hypertension during abortion induced by 15-methyl-prostaglandin F2alpha</atitle><jtitle>The American journal of medicine</jtitle><addtitle>Am J Med</addtitle><date>1976-04</date><risdate>1976</risdate><volume>60</volume><issue>4</issue><spage>556</spage><pages>556-</pages><issn>0002-9343</issn><abstract>Patients have experienced severe breathlessness during second trimester abortion initiated by the intramuscular injection of 15-methyl-prostaglandin F2alpha (15-me-PGF2alpha). In four healthy women given 400 mug of 15-me-PGF2alpha to induce abortion, pulmonary function tests showed reductions in arterial oxygen tension, maximum expired air flow and vital capacity. Residual lung volume and the slope of phase III of the closing volume curves increased.</abstract><cop>United States</cop><pmid>1274990</pmid><doi>10.1016/0002-9343(76)90723-3</doi></addata></record>
fulltext fulltext
identifier ISSN: 0002-9343
ispartof The American journal of medicine, 1976-04, Vol.60 (4), p.556
issn 0002-9343
language eng
recordid cdi_pubmed_primary_1274990
source MEDLINE; Elsevier ScienceDirect Journals
subjects Abortion, Induced - adverse effects
Adolescent
Adult
Blood Cell Count
Blood Pressure - drug effects
Bronchial Diseases - blood
Bronchial Diseases - chemically induced
Bronchial Diseases - physiopathology
Carbon Dioxide - blood
Female
Forced Expiratory Flow Rates
Functional Residual Capacity
Humans
Hypertension, Pulmonary - blood
Hypertension, Pulmonary - chemically induced
Hypertension, Pulmonary - physiopathology
Maximal Midexpiratory Flow Rate
Oxygen - blood
Pregnancy
Pregnancy Trimester, Second
Prostaglandins F - adverse effects
Prostaglandins F - pharmacology
Prostaglandins F - therapeutic use
Pulmonary Diffusing Capacity
Vital Capacity - drug effects
title Bronchoconstriction and pulmonary hypertension during abortion induced by 15-methyl-prostaglandin F2alpha
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T00%3A29%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bronchoconstriction%20and%20pulmonary%20hypertension%20during%20abortion%20induced%20by%2015-methyl-prostaglandin%20F2alpha&rft.jtitle=The%20American%20journal%20of%20medicine&rft.au=Weir,%20E%20K&rft.date=1976-04&rft.volume=60&rft.issue=4&rft.spage=556&rft.pages=556-&rft.issn=0002-9343&rft_id=info:doi/10.1016/0002-9343(76)90723-3&rft_dat=%3Cpubmed%3E1274990%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/1274990&rfr_iscdi=true